Presentation THT 2025 HFpEF in Focus: The Scientific Rationale for the Confirmatory RESPONDER HF Trial Presenter: Sanjiv Shah February 12, 2025
News Conference News THT 2024 Small Study Hints at Potential for HF Bone Marrow Cell Therapy: CardiAMP-HF Michael O'Riordan March 08, 2024
News Conference News THT 2024 Durable 1-Year Outcomes With Coronary Sinus Shunt for HF: ALT-FLOW EFS Michael O'Riordan March 06, 2024
Presentation THT 2024 AI Assisted Identification of Super responders for Ultrafiltration can Reduce 90-Day Readmission Rates: Evidence from AVOID-HF Trial Presenter: Deya Alkhatib March 06, 2024
News Conference News THT 2023 More Early Insights Into Interatrial Shunts in HF, but Little to Focus the Field Shelley Wood March 24, 2023
News Conference News THT 2023 REDUCE LAP-HF II Subanalysis Makes the Case for Invasive Exercise Tests Yael L. Maxwell March 22, 2023
News Conference News THT 2023 Preliminary Results Suggest Benefit of Splanchnic Nerve Ablation in HFpEF Todd Neale March 22, 2023
Presentation THT 2023 The PRELIEVE Trial: Responder Analysis in the HFpEF Subgroup Regarding Baseline PVR, Pacemaker and Pressure Gradients Presenter: NULL March 22, 2023
News Conference News THT 2023 Pulmonary Artery Denervation Makes Inroads in PAH Due to Left-Sided HF Shelley Wood March 21, 2023
News Conference News THT 2023 PCI’s Role for Patients With HFrEF and Extensive CAD: Experts Debate Todd Neale March 20, 2023
Presentation THT 2023 The PRELIEVE trial: Final 1-year outcomes of the prospective Atrial Flow Regulator study in HFrEF and HFpEF patients and post-hoc responder analysis Presenter: Christina Paitazoglou March 20, 2023
News Conference News THT 2022 Early Positive Signals From RELIEVE-HF Shift Discussion to Atrial Shunt Size Shelley Wood February 02, 2022
News Conference News THT 2022 REDUCE LAP-HF II: Atrial Shunt Device Comes Up Short in HFpEF Shelley Wood February 01, 2022